Thursday, 28 January 2021
This website uses cookies. By using our site you agree to our privacy policy
Username:
Password:
Lost username/password
Create an account
  • Home
  • About Us
    • Contributing Faculty
    • Supporters
    • Site Map
    • Accreditation
    • Press Room
    • Contact Us
  • Reference
    • Clinical Trial Highlights
    • Clinical Case Snapshots
    • Clinical Pearls Podcasts
    • Clinical Expert Commentaries
    • FAQ Library
    • Case Discussion
    • Downloadable Slides
    • Expert Interview Series
    • HL e-Newsletter Series
    • Articles
    • COVID-19 Resource Center
  • Conferences
  • Continuing Education
    • Accredited E-Newsletter Series
    • Annual Meeting Highlights
    • Practice Essentials
    • CD30 e-Monograph
    • Clinical Discussion Series
    • Commentaries in HL
    • Contemporary Therapy e-Monograph
  • CE for Nurses

Massimo Federico, MD

Director, Medical Oncology Unit
University of Modena and Reggio Emilia
President, Italian Lymphoma Foundation
Modena, Italy
Last modified: November 26, 2018
Authored Items
Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi
Massimo Federico, MD
ASH 2014: Highlights in Hodgkin Lymphoma published on December 16, 2014
What is the incidence of infertility in females with Hodgkin lymphoma? Is this a factor in males too?
Massimo Federico, MD
FAQ published on April 22, 2014
How is tumor burden measured and is this performed in every patient?
Massimo Federico, MD
FAQ published on February 12, 2014
Aspects of risk-adaptive therapy in advanced-stage Hodgkin lymphoma
Massimo Federico, MD
9th ISHL Highlights media published on November 4, 2013

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMDS.com | ManagingMPN.com | PartnersinPancreaticCancer.com | PracticalOncologist.com | EmergingSolutionsinPain.com | MediComWorldwide.com

©2021 MediCom Worldwide, Inc. All rights reserved

  • Privacy, Terms, and Conditions
  • Contact Us